Patents Assigned to American Pharmed Labs, Inc.
  • Publication number: 20020128285
    Abstract: A non-invasive and non-systemic method for intradermal prevention OR amelioration of pain from a surgically closed wound is disclosed. The method comprises topical delivery of a local anesthetic to an exterior surface of a surgically closed wound.
    Type: Application
    Filed: May 3, 2002
    Publication date: September 12, 2002
    Applicant: American Pharmed Labs, Inc.
    Inventor: R. Douglas Cassel
  • Patent number: 5840755
    Abstract: A composition for topical therapy of headaches, which contains a topical carrier system for intact mammalian skin of forehead or temples or both, which contains a therapeutically effective dose of a local anesthetic for delivery to a skin surface underneath the topical carrier system.
    Type: Grant
    Filed: July 17, 1996
    Date of Patent: November 24, 1998
    Assignee: American Pharmed Labs, Inc.
    Inventor: Rainer K. Liedtke
  • Patent number: 5776952
    Abstract: A composition for topical therapy for symptoms of back pain, muscle tension or myofascial pain or a combination thereof, which comprises a topical carrier system for intact skin of the back or outer synovial membranes or both, which comprises a therapeutic dose of a local anesthetic, and which applies the local anesthetic to a region of skin lying beneath the topical carrier system.
    Type: Grant
    Filed: July 17, 1996
    Date of Patent: July 7, 1998
    Assignee: American Pharmed Labs, Inc.
    Inventor: Rainer K. Liedtke
  • Patent number: 5686112
    Abstract: To improve the efficacy and tolerability of customary topical applications for transdermal systemically acting pharmaceutical substances, single dosage topical pharmaceutical forms which are therapeutically exactly ready-to-administer are formed from suitable semi-solid pharmaceutical forms. The topical single doses are specified pharmaceutically with respect to their dose, their topical spreading behaviour and their permeation properties. Several of the topically ready-to-administer single doses are in this case accommodated in a common commercial packaging container. Complex treatments can be developed by means of different individual dosages or alternatively active compound combinations. As pharmacological active compounds, steroids, peptides, various analgesics, local anaesthetics and non-steroidal antirheumatics are employed in particular.
    Type: Grant
    Filed: December 20, 1995
    Date of Patent: November 11, 1997
    Assignee: APL-American Pharmed Labs, Inc.
    Inventor: Rainer K. Liedtke